Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

And that’s a wrap on another great day of #EHA2021! @VJHemOnc are looking forward to listening to more tomorrow!

Check the latest #EHA21 news 🔶https://tinyurl.com/VJHO-EHA21🔶

Don’t forget to register for tomorrow’s #VJSocial session at 7PM CEST👉 https://vjhemoncsocial.com/👈

Facilitating positive coping styles accounts for most of the effect from a palliative care intervention on improving QOL & depression symptoms in #AML

Learn more from @tomleblancMD of @DukeCancer: http://ow.ly/itV150F4ISA

#ASCO21 @ASCO #HemOnc #Leukemia #AMLsm #Leusm #QoL

#EHA2021 📢@gilles_salles opens the session on considerations for the evolving R/R DLBCL treatment landscape

@VJHemOnc @EHA_Hematology #Lymsm #Lymphoma

Mark Levis of @KimmelCancerCtr talks on FF-10101-01 for R/R AML.

Watch: 👉http://ow.ly/S8e550F85Zd👈

@EHA_Hematology #EHA2021 @VJHemOnc #HemOnc #Leusm #Leukemia #AMLsm

We are LIVE at the #VJSocial Masterclass 🙌

It’s your last chance to register for the ‘Trending in #Lymphoma’ #VJSocial Session ⏰

Join the conversation here 💥http://vjhemoncsocial.com💥

#EHA2021 #EHA21 #Lymsm #HemOnc #DLBCL

Load More...

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

And that’s a wrap on another great day of #EHA2021! @VJHemOnc are looking forward to listening to more tomorrow!

Check the latest #EHA21 news 🔶https://tinyurl.com/VJHO-EHA21🔶

Don’t forget to register for tomorrow’s #VJSocial session at 7PM CEST👉 https://vjhemoncsocial.com/👈

Facilitating positive coping styles accounts for most of the effect from a palliative care intervention on improving QOL & depression symptoms in #AML

Learn more from @tomleblancMD of @DukeCancer: http://ow.ly/itV150F4ISA

#ASCO21 @ASCO #HemOnc #Leukemia #AMLsm #Leusm #QoL

#EHA2021 📢@gilles_salles opens the session on considerations for the evolving R/R DLBCL treatment landscape

@VJHemOnc @EHA_Hematology #Lymsm #Lymphoma

Mark Levis of @KimmelCancerCtr talks on FF-10101-01 for R/R AML.

Watch: 👉http://ow.ly/S8e550F85Zd👈

@EHA_Hematology #EHA2021 @VJHemOnc #HemOnc #Leusm #Leukemia #AMLsm

We are LIVE at the #VJSocial Masterclass 🙌

It’s your last chance to register for the ‘Trending in #Lymphoma’ #VJSocial Session ⏰

Join the conversation here 💥http://vjhemoncsocial.com💥

#EHA2021 #EHA21 #Lymsm #HemOnc #DLBCL

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter